{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:16Z","timestamp":1793229256424,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00213-018-5102-6","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T12:57:12Z","timestamp":1542718632000},"page":"1491-1512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-9079","authenticated-orcid":false,"given":"Karolina","family":"Skonieczna-\u017bydecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"\u0141oniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Misera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Stachowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Maciejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Marlicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Galling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"5102_CR1","doi-asserted-by":"publisher","unstructured":"Abbott A (2016) Scientists bust myth that our bodies have more bacteria than human cells. Nature News. \nhttps:\/\/doi.org\/10.1038\/nature.2016.19136","DOI":"10.1038\/nature.2016.19136"},{"key":"5102_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12967-018-1619-z","volume":"16","author":"JO Alem\u00e1n","year":"2018","unstructured":"Alem\u00e1n JO, Bokulich NA, Swann JR, Walker JM, de Rosa JC, Battaglia T, Costabile A, Pechlivanis A, Liang Y, Breslow JL, Blaser MJ, Holt PR (2018) Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women. J Transl Med 16:244. \nhttps:\/\/doi.org\/10.1186\/s12967-018-1619-z","journal-title":"J Transl Med"},{"key":"5102_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1192\/bjp.bp.107.042853","volume":"193","author":"M Alvarez-Jim\u00e9nez","year":"2008","unstructured":"Alvarez-Jim\u00e9nez M, Hetrick SE, Gonz\u00e1lez-Blanch C et al (2008) Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 193:101\u2013107. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.107.042853","journal-title":"Br J Psychiatry"},{"key":"5102_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/diacare.27.2.596","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596\u2013601","journal-title":"Diabetes Care"},{"key":"5102_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1473-3099(13)70179-8","volume":"13","author":"E Angelakis","year":"2013","unstructured":"Angelakis E, Merhej V, Raoult D (2013) Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 13:889\u2013899. \nhttps:\/\/doi.org\/10.1016\/S1473-3099(13)70179-8","journal-title":"Lancet Infect Dis"},{"key":"5102_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/ajcn\/69.6.1117","volume":"69","author":"A Astrup","year":"1999","unstructured":"Astrup A, G\u00f8tzsche PC, van de Werken K, Ranneries C, Toubro S, Raben A, Buemann B (1999) Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr 69:1117\u20131122. \nhttps:\/\/doi.org\/10.1093\/ajcn\/69.6.1117","journal-title":"Am J Clin Nutr"},{"key":"5102_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1073\/pnas.0605374104","volume":"104","author":"F B\u00e4ckhed","year":"2007","unstructured":"B\u00e4ckhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104:979\u2013984. \nhttps:\/\/doi.org\/10.1073\/pnas.0605374104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5102_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.135","volume":"5","author":"SM Bahr","year":"2015","unstructured":"Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR, Calarge CA (2015a) Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry 5:e652. \nhttps:\/\/doi.org\/10.1038\/tp.2015.135","journal-title":"Transl Psychiatry"},{"key":"5102_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.ebiom.2015.10.018","volume":"2","author":"SM Bahr","year":"2015","unstructured":"Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CML, Pearson NA, Murry DJ, Grobe JL, Kirby JR (2015b) Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2:1725\u20131734. \nhttps:\/\/doi.org\/10.1016\/j.ebiom.2015.10.018","journal-title":"EBioMedicine"},{"key":"5102_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094112","volume":"9","author":"M Bak","year":"2014","unstructured":"Bak M, Fransen A, Janssen J, van Os J, Drukker M (2014) Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 9:e94112. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0094112","journal-title":"PLoS One"},{"key":"5102_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","volume":"25","author":"JS Ballon","year":"2014","unstructured":"Ballon JS, Pajvani U, Freyberg Z, Leibel RL, Lieberman JA (2014) Molecular pathophysiology of metabolic effects of antipsychotic medications. Trends Endocrinol Metab 25:593\u2013600. \nhttps:\/\/doi.org\/10.1016\/j.tem.2014.07.004","journal-title":"Trends Endocrinol Metab"},{"key":"5102_CR12","first-page":"529","volume":"37","author":"I Beierle","year":"1999","unstructured":"Beierle I, Meibohm B, Derendorf H (1999) Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther 37:529\u2013547","journal-title":"Int J Clin Pharmacol Ther"},{"key":"5102_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8:42. \nhttps:\/\/doi.org\/10.1186\/s13073-016-0303-2","journal-title":"Genome Med"},{"key":"5102_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1152\/physiol.00023.2012","volume":"27","author":"R Burcelin","year":"2012","unstructured":"Burcelin R (2012) Regulation of metabolism: a cross talk between gut microbiota and its human host. Physiology (Bethesda) 27:300\u2013307. \nhttps:\/\/doi.org\/10.1152\/physiol.00023.2012","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"5102_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s13668-018-0248-8","volume":"7","author":"Edward S. Chambers","year":"2018","unstructured":"Chambers ES, Preston T, Frost G, Morrison DJ (2018) Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Curr Nutr Rep. \nhttps:\/\/doi.org\/10.1007\/s13668-018-0248-8","journal-title":"Current Nutrition Reports"},{"key":"5102_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019590","volume":"6","author":"C-K Chang","year":"2011","unstructured":"Chang C-K, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, Hotopf M, Stewart R (2011) Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One 6:e19590. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0019590","journal-title":"PLoS One"},{"key":"5102_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","volume":"108","author":"AF Chintoh","year":"2009","unstructured":"Chintoh AF, Mann SW, Lam L, Giacca A, Fletcher P, Nobrega J, Remington G (2009) Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophr Res 108:127\u2013133. \nhttps:\/\/doi.org\/10.1016\/j.schres.2008.12.012","journal-title":"Schizophr Res"},{"key":"5102_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2012.77","volume":"18","author":"G Clarke","year":"2013","unstructured":"Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18:666\u2013673. \nhttps:\/\/doi.org\/10.1038\/mp.2012.77","journal-title":"Mol Psychiatry"},{"key":"5102_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","volume":"10","author":"SM Collins","year":"2012","unstructured":"Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10:735\u2013742. \nhttps:\/\/doi.org\/10.1038\/nrmicro2876","journal-title":"Nat Rev Microbiol"},{"key":"5102_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"THMP Consortium","year":"2012","unstructured":"Consortium THMP, Huttenhower C, Gevers D et al (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207\u2013214. \nhttps:\/\/doi.org\/10.1038\/nature11234","journal-title":"Nature"},{"key":"5102_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1079\/PNS2001110","volume":"60","author":"SW Coppack","year":"2001","unstructured":"Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349\u2013356","journal-title":"Proc Nutr Soc"},{"key":"5102_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, Z\u00e1rate Rodriguez JG, Rogers AB, Robine N, Loke P\u2019, Blaser MJ (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705\u2013721. \nhttps:\/\/doi.org\/10.1016\/j.cell.2014.05.052","journal-title":"Cell"},{"issue":"5","key":"5102_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","volume":"236","author":"Sofia Cussotto","year":"2018","unstructured":"Cussotto S, Strain CR, Fouhy F, Strain RG, Peterson VL, Clarke G, Stanton C, Dinan TG, Cryan JF (2018) Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology. \nhttps:\/\/doi.org\/10.1007\/s00213-018-5006-5","journal-title":"Psychopharmacology"},{"key":"5102_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","volume":"221","author":"KJ Davey","year":"2012","unstructured":"Davey KJ, O\u2019Mahony SM, Schellekens H, O\u2019Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF (2012) Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221:155\u2013169. \nhttps:\/\/doi.org\/10.1007\/s00213-011-2555-2","journal-title":"Psychopharmacology"},{"key":"5102_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.83","volume":"3","author":"KJ Davey","year":"2013","unstructured":"Davey KJ, Cotter PD, O\u2019Sullivan O et al (2013) Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 3:e309. \nhttps:\/\/doi.org\/10.1038\/tp.2013.83","journal-title":"Transl Psychiatry"},{"key":"5102_CR26","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/NDT.S113099","volume":"13","author":"M Dayabandara","year":"2017","unstructured":"Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva V (2017) Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat 13:2231\u20132241. \nhttps:\/\/doi.org\/10.2147\/NDT.S113099","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5102_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.bp.110.084665","volume":"199","author":"M Hert De","year":"2011","unstructured":"De Hert M, Vancampfort D, Correll CU et al (2011) Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 199:99\u2013105. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.110.084665","journal-title":"Br J Psychiatry"},{"key":"5102_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrendo.2011.126","volume":"7","author":"NM Delzenne","year":"2011","unstructured":"Delzenne NM, Neyrinck AM, B\u00e4ckhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639\u2013646. \nhttps:\/\/doi.org\/10.1038\/nrendo.2011.126","journal-title":"Nat Rev Endocrinol"},{"key":"5102_CR29","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Besten den","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325\u20132340. \nhttps:\/\/doi.org\/10.1194\/jlr.R036012","journal-title":"J Lipid Res"},{"key":"5102_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0091-3057(03)00079-0","volume":"75","author":"DS Dwyer","year":"2003","unstructured":"Dwyer DS, Donohoe D (2003) Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol Biochem Behav 75:255\u2013260","journal-title":"Pharmacol Biochem Behav"},{"key":"5102_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.1890","volume":"37","author":"SA Flowers","year":"2017","unstructured":"Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL (2017) Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37:261\u2013267. \nhttps:\/\/doi.org\/10.1002\/phar.1890","journal-title":"Pharmacotherapy"},{"key":"5102_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/14740338.2015.979150","volume":"14","author":"B Galling","year":"2015","unstructured":"Galling B, Correll CU (2015) Do antipsychotics increase diabetes risk in children and adolescents? Expert Opin Drug Saf 14:219\u2013241. \nhttps:\/\/doi.org\/10.1517\/14740338.2015.979150","journal-title":"Expert Opin Drug Saf"},{"key":"5102_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","volume":"73","author":"B Galling","year":"2016","unstructured":"Galling B, Rold\u00e1n A, Nielsen RE, Nielsen J, Gerhard T, Carbon M, Stubbs B, Vancampfort D, de Hert M, Olfson M, Kahl KG, Martin A, Guo JJ, Lane HY, Sung FC, Liao CH, Arango C, Correll CU (2016) Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis. JAMA Psychiatry 73:247\u2013259. \nhttps:\/\/doi.org\/10.1001\/jamapsychiatry.2015.2923","journal-title":"JAMA Psychiatry"},{"key":"5102_CR34","doi-asserted-by":"publisher","first-page":"857.2","DOI":"10.1096\/fasebj.29.1_supplement.857.2","volume":"29","author":"J Grobe","year":"2015","unstructured":"Grobe J, Bahr S, Weidemann B et al (2015) Transfer of obesity via the gut microbiome is mediated specifically through suppression of non-aerobic resting metabolism. FASEB J 29:857.2. \nhttps:\/\/doi.org\/10.1096\/fasebj.29.1_supplement.857.2","journal-title":"FASEB J"},{"key":"5102_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","volume":"27","author":"\u00d3 H\u00e1lfd\u00e1narson","year":"2017","unstructured":"H\u00e1lfd\u00e1narson \u00d3, Zo\u00ebga H, Aagaard L, Bernardo M, Brandt L, Fust\u00e9 AC, Furu K, Garuolien\u00e9 K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, L\u00f3pez SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ (2017) International trends in antipsychotic use: a study in 16 countries, 2005-2014. Eur Neuropsychopharmacol 27:1064\u20131076. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2017.07.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"5102_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2165\/00003495-199550020-00003","volume":"50","author":"RZ Harris","year":"1995","unstructured":"Harris RZ, Benet LZ, Schwartz JB (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222\u2013239","journal-title":"Drugs"},{"key":"5102_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000481519","volume":"10","author":"CN Heiss","year":"2017","unstructured":"Heiss CN, Olofsson LE (2017) Gut microbiota-dependent modulation of energy metabolism. J Innate Immun 10:163\u2013171. \nhttps:\/\/doi.org\/10.1159\/000481519","journal-title":"J Innate Immun"},{"key":"5102_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179\u2013185. \nhttps:\/\/doi.org\/10.1038\/nature10809","journal-title":"Nature"},{"key":"5102_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. \nhttps:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"5102_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/0706743717718166","volume":"62","author":"D Ilies","year":"2017","unstructured":"Ilies D, Huet A-S, Lacourse E, Roy G, Stip E, Amor LB (2017) Long-term metabolic effects in French-Canadian children and adolescents treated with second-generation antipsychotics in monotherapy or Polytherapy: a 24-month descriptive retrospective study. Can J Psychiatr 62:827\u2013836. \nhttps:\/\/doi.org\/10.1177\/0706743717718166","journal-title":"Can J Psychiatr"},{"key":"5102_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jgh.13488","volume":"32","author":"CJ Jin","year":"2017","unstructured":"Jin CJ, Engstler AJ, Ziegenhardt D, Bischoff SC, Trautwein C, Bergheim I (2017) Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice. J Gastroenterol Hepatol 32:708\u2013715. \nhttps:\/\/doi.org\/10.1111\/jgh.13488","journal-title":"J Gastroenterol Hepatol"},{"key":"5102_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","volume":"11","author":"LJ Kalverdijk","year":"2017","unstructured":"Kalverdijk LJ, Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Hoffmann F, Petersen I, Schuiling-Veninga CCM, Wijlaars LP, Zito JM (2017) A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012. Child Adolesc Psychiatry Ment Health 11:55. \nhttps:\/\/doi.org\/10.1186\/s13034-017-0192-1","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"5102_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00406-017-0820-z","volume":"268","author":"S Kanji","year":"2018","unstructured":"Kanji S, Fonseka TM, Marshe VS, Sriretnakumar V, Hahn MK, M\u00fcller DJ (2018) The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain. Eur Arch Psychiatry Clin Neurosci 268:3\u201315. \nhttps:\/\/doi.org\/10.1007\/s00406-017-0820-z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"5102_CR44","doi-asserted-by":"publisher","unstructured":"Kao AC-C, Spitzer S, Anthony DC, Lennox B, Burnet PWJ (2018) Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota. Transl Psychiatry:8. \nhttps:\/\/doi.org\/10.1038\/s41398-018-0116-8","DOI":"10.1038\/s41398-018-0116-8"},{"key":"5102_CR45","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/sj.ijo.0803259","volume":"30","author":"C-S Kim","year":"2006","unstructured":"Kim C-S, Park H-S, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 30:1347\u20131355. \nhttps:\/\/doi.org\/10.1038\/sj.ijo.0803259","journal-title":"Int J Obes"},{"key":"5102_CR46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","volume":"4","author":"I Kimura","year":"2013","unstructured":"Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, Takahashi T, Miyauchi S, Shioi G, Inoue H, Tsujimoto G (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4:1829. \nhttps:\/\/doi.org\/10.1038\/ncomms2852","journal-title":"Nat Commun"},{"key":"5102_CR47","first-page":"317","volume":"87","author":"JE Kristiansen","year":"1979","unstructured":"Kristiansen JE (1979) Experiments to illustrate the effect of chlorpromazine on the permeability of the bacterial cell wall. Acta Pathol Microbiol Scand B 87:317\u2013319","journal-title":"Acta Pathol Microbiol Scand B"},{"issue":"5","key":"5102_CR48","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.pharep.2015.01.017","volume":"67","author":"Marek Krzystanek","year":"2015","unstructured":"Krzystanek M, Bogus K, Pa\u0142asz A, et al (2015) Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus. Pharmacol Rep 67:965\u2013969. \nhttps:\/\/doi.org\/10.1016\/j.pharep.2015.01.017","journal-title":"Pharmacological Reports"},{"issue":"5","key":"5102_CR49","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.pharep.2016.05.009","volume":"68","author":"Marek Krzystanek","year":"2016","unstructured":"Krzystanek M, Bogus K, Pa\u0142asz A, et al (2016) Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon. Pharmacol Rep 68:990\u2013995. \nhttps:\/\/doi.org\/10.1016\/j.pharep.2016.05.009","journal-title":"Pharmacological Reports"},{"key":"5102_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4274\/jcrpe.3682","volume":"9","author":"T K\u00fcme","year":"2017","unstructured":"K\u00fcme T, Acar S, Tuhan H, \u00c7atl\u0131 G, An\u0131k A, G\u00fcrsoy \u00c7alan \u00d6, B\u00f6ber E, Abac\u0131 A (2017) The relationship between serum Zonulin level and clinical and laboratory parameters of childhood obesity. J Clin Res Pediatr Endocrinol 9:31\u201338. \nhttps:\/\/doi.org\/10.4274\/jcrpe.3682","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5102_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1054\/npep.1999.0048","volume":"33","author":"W Langhans","year":"1999","unstructured":"Langhans W, Hrupka B (1999) Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33:415\u2013424. \nhttps:\/\/doi.org\/10.1054\/npep.1999.0048","journal-title":"Neuropeptides"},{"key":"5102_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/JCP.0000000000000476","volume":"36","author":"SL Lau","year":"2016","unstructured":"Lau SL, Muir C, Assur Y, Beach R, Tran B, Bartrop R, McLean M, Caetano D (2016) Predicting weight gain in patients treated with clozapine: the role of sex, body mass index, and smoking. J Clin Psychopharmacol 36:120\u2013124. \nhttps:\/\/doi.org\/10.1097\/JCP.0000000000000476","journal-title":"J Clin Psychopharmacol"},{"key":"5102_CR53","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1073\/pnas.0504978102","volume":"102","author":"RE Ley","year":"2005","unstructured":"Ley RE, B\u00e4ckhed F, Turnbaugh P et al (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102:11070\u201311075. \nhttps:\/\/doi.org\/10.1073\/pnas.0504978102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5102_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pnpbp.2014.12.001","volume":"58","author":"ML Lu","year":"2015","unstructured":"Lu ML, Wang TN, Lin TY, Shao WC, Chang SH, Chou JY, Ho YF, Liao YT, Chen VCH (2015) Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin. Prog Neuro-Psychopharmacol Biol Psychiatry 58:47\u201350. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2014.12.001","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5102_CR55","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1586\/ern.10.85","volume":"10","author":"L Maayan","year":"2010","unstructured":"Maayan L, Correll CU (2010) Management of antipsychotic-related weight gain. Expert Rev Neurother 10:1175\u20131200. \nhttps:\/\/doi.org\/10.1586\/ern.10.85","journal-title":"Expert Rev Neurother"},{"key":"5102_CR56","doi-asserted-by":"publisher","unstructured":"Maciejewska D, Skonieczna-Zydecka K, Lukomska A, et al (2018) The short chain fatty acids and lipopolysaccharides status in Sprague-Dawley rats fed with high-fat and high-cholesterol diet. J Physiol Pharmacol 69. doi: \nhttps:\/\/doi.org\/10.26402\/jpp.2018.2.05","DOI":"10.26402\/jpp.2018.2.05"},{"key":"5102_CR57","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623\u2013628. \nhttps:\/\/doi.org\/10.1038\/nature25979","journal-title":"Nature"},{"key":"5102_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5114\/noms.2014.44566","volume":"1","author":"W Marlicz","year":"2014","unstructured":"Marlicz W, Ostrowska L, \u0141oniewski I (2014) Review paper<br>the role of gut microbiota in weight management by non-invasive interventions and bariatric surgery. Nutrition, Obesity & Metabolic Surgery 1:20\u201329. \nhttps:\/\/doi.org\/10.5114\/noms.2014.44566","journal-title":"Nutrition, Obesity & Metabolic Surgery"},{"key":"5102_CR59","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/oby.21385","volume":"24","author":"R Mathur","year":"2016","unstructured":"Mathur R, Chua KS, Mamelak M, Morales W, Barlow GM, Thomas R, Stefanovski D, Weitsman S, Marsh Z, Bergman RN, Pimentel M (2016) Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. Obesity (Silver Spring) 24:576\u2013582. \nhttps:\/\/doi.org\/10.1002\/oby.21385","journal-title":"Obesity (Silver Spring)"},{"key":"5102_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115225","volume":"9","author":"AP Morgan","year":"2014","unstructured":"Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, Bogue MA, Paredes SH, Yourstone S, Carroll IM, Kawula TH, Bower MA, Sartor RB, Sullivan PF (2014) The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS One 9:e115225. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0115225","journal-title":"PLoS One"},{"key":"5102_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.foodchem.2017.09.149","volume":"243","author":"B Muszy\u0144ska","year":"2018","unstructured":"Muszy\u0144ska B, Grzywacz-Kisielewska A, Ka\u0142a K, Gdula-Argasi\u0144ska J (2018) Anti-inflammatory properties of edible mushrooms: a review. Food Chem 243:373\u2013381. \nhttps:\/\/doi.org\/10.1016\/j.foodchem.2017.09.149","journal-title":"Food Chem"},{"issue":"Suppl 1","key":"5102_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000479918","volume":"71","author":"R Nagpal","year":"2017","unstructured":"Nagpal R, Yadav H (2017) Bacterial translocation from the gut to the distant organs: an overview. Ann Nutr Metab 71(Suppl 1):11\u201316. \nhttps:\/\/doi.org\/10.1159\/000479918","journal-title":"Ann Nutr Metab"},{"key":"5102_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189950","volume":"13","author":"H Nehme","year":"2018","unstructured":"Nehme H, Saulnier P, Ramadan AA, Cassisa V, Guillet C, Eveillard M, Umerska A (2018) Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. PLoS One 13:e0189950. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0189950","journal-title":"PLoS One"},{"key":"5102_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11894-017-0600-y","volume":"19","author":"E Omer","year":"2017","unstructured":"Omer E, Atassi H (2017) The microbiome that shapes us: can it cause obesity? Curr Gastroenterol Rep 19:59. \nhttps:\/\/doi.org\/10.1007\/s11894-017-0600-y","journal-title":"Curr Gastroenterol Rep"},{"key":"5102_CR65","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1530\/ERC-11-0163","volume":"18","author":"J Park","year":"2011","unstructured":"Park J, Scherer PE (2011) Leptin and cancer: from cancer stem cells to metastasis. Endocr Relat Cancer 18:C25\u2013C29. \nhttps:\/\/doi.org\/10.1530\/ERC-11-0163","journal-title":"Endocr Relat Cancer"},{"key":"5102_CR66","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","volume":"11","author":"M Raman","year":"2013","unstructured":"Raman M, Ahmed I, Gillevet PM et al (2013) Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11:868\u2013875.e1\u20133. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2013.02.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5102_CR67","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1177\/0269881117722987","volume":"31","author":"GP Reynolds","year":"2017","unstructured":"Reynolds GP, McGowan OO (2017) Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. J Psychopharmacol (Oxford) 31:1430\u20131436. \nhttps:\/\/doi.org\/10.1177\/0269881117722987","journal-title":"J Psychopharmacol (Oxford)"},{"key":"5102_CR68","doi-asserted-by":"publisher","first-page":"890.2","DOI":"10.1096\/fasebj.31.1_supplement.890.2","volume":"31","author":"RA Riedl","year":"2017","unstructured":"Riedl RA, Burnett CM, Pearson NA et al (2017) The biomass and composition of the gut microbiota modify anaerobic metabolism. FASEB J 31:890.2\u2013890.2. \nhttps:\/\/doi.org\/10.1096\/fasebj.31.1_supplement.890.2","journal-title":"FASEB J"},{"key":"5102_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/MCO.0000000000000419","volume":"20","author":"M Roman\u00ed-P\u00e9rez","year":"2017","unstructured":"Roman\u00ed-P\u00e9rez M, Agusti A, Sanz Y (2017) Innovation in microbiome-based strategies for promoting metabolic health. Curr Opin Clin Nutr Metab Care 20:484\u2013491. \nhttps:\/\/doi.org\/10.1097\/MCO.0000000000000419","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"5102_CR70","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/ijms18071431","volume":"18","author":"Rodrigo Rorato","year":"2017","unstructured":"Rorato R, de Borges BC, Uchoa ET et al (2017) LPS-induced low-grade inflammation increases hypothalamic JNK expression and causes central insulin resistance irrespective of body weight changes. Int J Mol Sci:18. \nhttps:\/\/doi.org\/10.3390\/ijms18071431","journal-title":"International Journal of Molecular Sciences"},{"key":"5102_CR71","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","volume":"10","author":"M Saberi","year":"2009","unstructured":"Saberi M, Woods N-B, de Luca C, Schenk S, Lu JC, Bandyopadhyay G, Verma IM, Olefsky JM (2009) Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 10:419\u2013429. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2009.09.006","journal-title":"Cell Metab"},{"key":"5102_CR72","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1871530317666171120151201","volume":"18","author":"V Sanchez-Martinez","year":"2017","unstructured":"Sanchez-Martinez V, Romero-Rubio D, Abad-Perez MJ, Descalzo-Cabades MA, Alonso-Gutierrez S, Salazar-Fraile J, Montagud V, Facila L (2017) Metabolic syndrome and cardiovascular risk in people treated with long-acting injectable antipsychotics. Endocr Metab Immune Disord Drug Targets 18:379\u2013387. \nhttps:\/\/doi.org\/10.2174\/1871530317666171120151201","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"5102_CR73","doi-asserted-by":"publisher","first-page":"16643","DOI":"10.1038\/srep16643","volume":"5","author":"M Schneeberger","year":"2015","unstructured":"Schneeberger M, Everard A, G\u00f3mez-Valad\u00e9s AG, Matamoros S, Ram\u00edrez S, Delzenne NM, Gomis R, Claret M, Cani PD (2015) Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep 5:16643. \nhttps:\/\/doi.org\/10.1038\/srep16643","journal-title":"Sci Rep"},{"key":"5102_CR74","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.schres.2017.04.017","volume":"192","author":"E Schwarz","year":"2018","unstructured":"Schwarz E, Maukonen J, Hyyti\u00e4inen T, Kiesepp\u00e4 T, Ore\u0161i\u010d M, Sabunciyan S, Mantere O, Saarela M, Yolken R, Suvisaari J (2018) Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res 192:398\u2013403. \nhttps:\/\/doi.org\/10.1016\/j.schres.2017.04.017","journal-title":"Schizophr Res"},{"key":"5102_CR75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/oby.2009.167","volume":"18","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18:190\u2013195. \nhttps:\/\/doi.org\/10.1038\/oby.2009.167","journal-title":"Obesity (Silver Spring)"},{"key":"5102_CR76","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647","journal-title":"BMJ"},{"key":"5102_CR77","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1089\/cap.2016.0171","volume":"27","author":"CP Sjo","year":"2017","unstructured":"Sjo CP, Stenstr\u00f8m AD, Bojesen AB, Fr\u00f8lich JS, Bilenberg N (2017) Development of metabolic syndrome in drug-naive adolescents after 12 months of second-generation antipsychotic treatment. J Child Adolesc Psychopharmacol 27:884\u2013891. \nhttps:\/\/doi.org\/10.1089\/cap.2016.0171","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"5102_CR78","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.2174\/1381612822666160922165706","volume":"22","author":"A Slyepchenko","year":"2016","unstructured":"Slyepchenko A, Maes M, Machado-Vieira R, Anderson G, Solmi M, Sanz Y, Berk M, K\u00f6hler C, Carvalho A (2016) Intestinal Dysbiosis, gut Hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes. Curr Pharm Des 22:6087\u20136106","journal-title":"Curr Pharm Des"},{"key":"5102_CR79","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","volume":"140","author":"MD Spencer","year":"2011","unstructured":"Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA (2011) Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140:976\u2013986. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2010.11.049","journal-title":"Gastroenterology"},{"key":"5102_CR80","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1210\/jc.2002-020135","volume":"87","author":"M Straczkowski","year":"2002","unstructured":"Straczkowski M, Dzienis-Straczkowska S, St\u00eapie\u00f1 A, Kowalska I, Szelachowska M, Kinalska I (2002) Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87:4602\u20134606. \nhttps:\/\/doi.org\/10.1210\/jc.2002-020135","journal-title":"J Clin Endocrinol Metab"},{"key":"5102_CR81","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/gut.2009.190959","volume":"58","author":"H Tilg","year":"2009","unstructured":"Tilg H, Kaser A (2009) Adiponectin and JNK: metabolic\/inflammatory pathways affecting gastrointestinal carcinogenesis. Gut 58:1576\u20131577. \nhttps:\/\/doi.org\/10.1136\/gut.2009.190959","journal-title":"Gut"},{"key":"5102_CR82","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1172\/JCI58109","volume":"121","author":"H Tilg","year":"2011","unstructured":"Tilg H, Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121:2126\u20132132. \nhttps:\/\/doi.org\/10.1172\/JCI58109","journal-title":"J Clin Invest"},{"key":"5102_CR83","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","volume":"489","author":"V Tremaroli","year":"2012","unstructured":"Tremaroli V, B\u00e4ckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242\u2013249. \nhttps:\/\/doi.org\/10.1038\/nature11552","journal-title":"Nature"},{"key":"5102_CR84","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.chom.2017.02.021","volume":"21","author":"PJ Turnbaugh","year":"2017","unstructured":"Turnbaugh PJ (2017) Microbes and diet-induced obesity: fast, cheap, and out of control. Cell Host Microbe 21:278\u2013281. \nhttps:\/\/doi.org\/10.1016\/j.chom.2017.02.021","journal-title":"Cell Host Microbe"},{"key":"5102_CR85","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027\u20131031. \nhttps:\/\/doi.org\/10.1038\/nature05414","journal-title":"Nature"},{"key":"5102_CR86","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI (2009) A core gut microbiome in obese and lean twins. Nature 457:480\u2013484. \nhttps:\/\/doi.org\/10.1038\/nature07540","journal-title":"Nature"},{"key":"5102_CR87","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1113\/JP276431","volume":"596","author":"M Wouw van de","year":"2018","unstructured":"van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF (2018) Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol Lond 596:4923\u20134944. \nhttps:\/\/doi.org\/10.1113\/JP276431","journal-title":"J Physiol Lond"},{"key":"5102_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/wps.20309","volume":"15","author":"D Vancampfort","year":"2016","unstructured":"Vancampfort D, Correll CU, Galling B, Probst M, de Hert M, Ward PB, Rosenbaum S, Gaughran F, Lally J, Stubbs B (2016) Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 15:166\u2013174. \nhttps:\/\/doi.org\/10.1002\/wps.20309","journal-title":"World Psychiatry"},{"key":"5102_CR89","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative (2014) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500\u20131524. \nhttps:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014","journal-title":"Int J Surg"},{"key":"5102_CR90","unstructured":"Vasan S, Abdijadid S (2018) Atypical antipsychotic agents. In: StatPearls. StatPearls publishing, Treasure Island (FL)"},{"key":"5102_CR91","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s40618-017-0719-6","volume":"40","author":"AA Verhaegen","year":"2017","unstructured":"Verhaegen AA, Van Gaal LF (2017) Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Investig 40:1165\u20131174. \nhttps:\/\/doi.org\/10.1007\/s40618-017-0719-6","journal-title":"J Endocrinol Investig"},{"key":"5102_CR92","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"GA Weiss","year":"2017","unstructured":"Weiss GA, Hennet T (2017) Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci 74:2959\u20132977. \nhttps:\/\/doi.org\/10.1007\/s00018-017-2509-x","journal-title":"Cell Mol Life Sci"},{"key":"5102_CR93","first-page":"231","volume":"22","author":"E Wirostko","year":"1990","unstructured":"Wirostko E, Johnson L, Wirostko B (1990) Ulcerative colitis associated chronic uveitis. Parasitization of intraocular leucocytes by mollicute-like organisms J Submicrosc Cytol Pathol 22:231\u2013239","journal-title":"Parasitization of intraocular leucocytes by mollicute-like organisms J Submicrosc Cytol Pathol"},{"key":"5102_CR94","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI19451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821\u20131830. \nhttps:\/\/doi.org\/10.1172\/JCI19451","journal-title":"J Clin Invest"},{"key":"5102_CR95","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3349\/ymj.2017.58.6.1083","volume":"58","author":"BG Yang","year":"2017","unstructured":"Yang BG, Hur KY, Lee MS (2017) Alterations in gut microbiota and immunity by dietary fat. Yonsei Med J 58:1083\u20131091. \nhttps:\/\/doi.org\/10.3349\/ymj.2017.58.6.1083","journal-title":"Yonsei Med J"},{"key":"5102_CR96","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.schres.2018.05.017","volume":"201","author":"Xiuxia Yuan","year":"2018","unstructured":"Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan X, Song X (2018) Changes in metabolism and microbiota after 24-week risperidone treatment in drug na\u00efve, normal weight patients with first episode schizophrenia. Schizophr Res. \nhttps:\/\/doi.org\/10.1016\/j.schres.2018.05.017","journal-title":"Schizophrenia Research"},{"key":"5102_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054250","volume":"8","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Zhu Y, Zhou W, Gao L, Yuan L, Han X (2013) Serotonin receptor 2C and insulin secretion. PLoS One 8:e54250. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0054250","journal-title":"PLoS One"},{"key":"5102_CR98","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","volume":"42","author":"J-P Zhang","year":"2016","unstructured":"Zhang J-P, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU (2016) Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr Bull 42:1418\u20131437. \nhttps:\/\/doi.org\/10.1093\/schbul\/sbw058","journal-title":"Schizophr Bull"},{"key":"5102_CR99","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","volume":"37","author":"U Zimmermann","year":"2003","unstructured":"Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollm\u00e4cher T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37:193\u2013220","journal-title":"J Psychiatr Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5102-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5102-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5102-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T19:10:36Z","timestamp":1574190636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5102-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["5102"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5102-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}